Primary Mebranous Nephropathy Pmn clinical trials

Explore recruiting primary mebranous nephropathy pmn clinical trials.

Also recruiting in Europe

Primary Mebranous Nephropathy Pmn trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1920 in Adult Participants with PMN (Primary Membranous Nephropathy) who are at a High Risk for Disease Progression (AUTUMN)

Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Primary Mebranous Nephropathy Pmn trials by city

Primary Mebranous Nephropathy Pmn in Toronto Primary Mebranous Nephropathy Pmn in Vancouver Primary Mebranous Nephropathy Pmn in Montreal Primary Mebranous Nephropathy Pmn in Calgary Primary Mebranous Nephropathy Pmn in Edmonton Primary Mebranous Nephropathy Pmn in Ottawa Primary Mebranous Nephropathy Pmn in Winnipeg Primary Mebranous Nephropathy Pmn in Quebec City Primary Mebranous Nephropathy Pmn in Hamilton Primary Mebranous Nephropathy Pmn in Kitchener Primary Mebranous Nephropathy Pmn in London Primary Mebranous Nephropathy Pmn in Halifax Primary Mebranous Nephropathy Pmn in New York Primary Mebranous Nephropathy Pmn in Los Angeles Primary Mebranous Nephropathy Pmn in Chicago Primary Mebranous Nephropathy Pmn in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease